Recce (ASX:RCE) share price edges higher after patent approval

The Recce Pharmaceuticals Ltd (ASX: RCE) share price ended the day higher after the company secured a patent in the United States.

At the closing bell, the pharmaceutical company’s shares finished the day up 3.27% to $1.10.

Let’s take a…